Paraskevi Tsonou

Paraskevi Tsonou

Auto-generated profile, based on publicly available information

Paraskevi Tsonou

Department of Travel Medicine, National Public Health Organization, Athens, Greece

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2021 in Hellenic Journal of Cardiology
Verified
Journal Article
Open access
EVANGELOS OIKONOMOUEVANGELOS OIKONOMOU
EVANGELOS OIKONOMOU
APAngelos Papanikolaou
Angelos Papanikolaou
AAAris Anastasakis
Aris Anastasakis
EBElefterios Bournousouzis
Elefterios Bournousouzis
CGChristos Georgakopoulos
Christos Georgakopoulos
CVCharalambos Vlachopoulos
Charalambos Vlachopoulos

9 February 2022 in Hormones
Verified
Journal Article
Open access
PDF file
Helena MaltezouHelena Maltezou
Helena Maltezou
APAndroula Pavli
Androula Pavli
PTParaskevi Tsonou
Paraskevi Tsonou
ABAsimina Balaska
Asimina Balaska
VRVASILIOS RAFTOPOULOS
VASILIOS RAFTOPOULOS
NTNikolaos Tentolouris
Nikolaos Tentolouris
Purpose Our aim was to study patients with diabetes mellitus and SARS-CoV-2-infection diagnosed during the first pandemic wave in Greece. Methods Cases were retrieved from the national database of SARS-CoV-2 infections. Results We studied 2624 SARS-CoV-2 infected cases, including 157 with diabetes. Patients with diabetes more often had other comorbidities (68.8 vs. 24.1%; p-value < 0.001). Among patients with diabetes, 149 (94.9%) developed symptomatic disease (COVID-19) compared to 1817 patients (73.7%) without diabetes (p-value < 0.001). A total of 126 patients with diabetes and COVID-19 were hospitalized and 41 died (27.5% case-fatality rate compared to 7.5% among patients without diabetes; p-value < 0.001). Patients with diabetes more often were hospitalized, developed complications, were admitted to the intensive care unit (ICU), received invasive mechanical ventilation, and died compared to patients without diabetes (p-values < 0.001 to 0.002 for all comparisons). Multivariate logistic regression analyses revealed that diabetes, having other comorbidities, and older age were significantly associated with higher risk for hospitalization, ICU admission, invasive mechanical ventilation, and death, and that obesity was significantly associated with higher risk for hospitalization, ICU admission, and mechanical intubation, while female gender protected against these outcomes. Conclusion COVID-19 is associated with increased rates of serious morbidity and adverse outcome in patients with diabetes and represents a severe illness for them.